How do you approach revascularization in patients over 75 years with NSTEMI, given recent evidence from the SENIOR-RITA trial that an invasive strategy does not significantly reduce cardiovascular events compared to a conservative strategy?
Kunadian, et al., PMID 39225274
Community PollStarted
Do the results of the SENIOR-RITA trial change your invasive practice strategy for elderly patient?
36 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Cardiology · University Of California San Francisco Medical Center At Parnassus
Answered on
The Senior-Rita trial was a randomized trial of nstemi patients over the age of 75 randomized to conservative therapy versus an invasive strategy plus optimal medical therapy. Non-fatal MI was more common in the conservative strategy group but overall a primary outcome event occurred in 25-26% in bo...
Join for free or sign in to see the full answer